Mirae Asset Global Etfs Holdings Ltd. Collegium Pharmaceutical, Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 18,221 shares of COLL stock, worth $526,769. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,221
Previous 17,882
1.9%
Holding current value
$526,769
Previous $690,000
24.35%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding COLL
# of Institutions
247Shares Held
37.4MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$167 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$76.3 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$67.9 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$66 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$61.9 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $987M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...